Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling | Journal of Experimental & Clinical Cancer Research | Full Text

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling | Journal of Experimental & Clinical Cancer Research | Full Text

Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling

Sirtuin 6 (Sirt6) is a highly conserved ADP-ribosylase and NAD+ dependent deacylase, involved in broad cellular processes. This molecule possesses contradictory roles in carcinogenesis, as it has been document...

Authors:Juan Yang, Ying Li, Ya Zhang, Xiaosheng Fang, Na Chen, Xiangxiang Zhou and Xin Wang

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:142

Content type:Research

 

Published on: 25 July 2020

• ViewFull Text
 
• ViewPDF